IMPDH2

Chr 3

inosine monophosphate dehydrogenase 2

Also known as: IMPD2, IMPDH-II

This gene encodes the rate-limiting enzyme in the de novo guanine nucleotide biosynthesis. It is thus involved in maintaining cellular guanine deoxy- and ribonucleotide pools needed for DNA and RNA synthesis. The encoded protein catalyzes the NAD-dependent oxidation of inosine-5'-monophosphate into xanthine-5'-monophosphate, which is then converted into guanosine-5'-monophosphate. This gene is up-regulated in some neoplasms, suggesting it may play a role in malignant transformation. [provided by RefSeq, Jul 2008]

ResearchGenerating clinical summary…
0
Active trials
54
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
0.80
LOEUF
DN
Mechanism· predicted
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.80LOEUF
pLI 0.000
Z-score 2.35
OE 0.50 (0.33–0.80)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
2.50Z-score
OE missense 0.59 (0.52–0.67)
176 obs / 297.5 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.50 (0.33–0.80)
0≤0.351.4
Missense OE?0.59 (0.52–0.67)
0≤0.61.4
Synonymous OE?1.11
0≤1.21.6
LoF obs/exp: 13 / 25.9Missense obs/exp: 176 / 297.5Syn Z: -0.93

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

IMPDH2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →